This content is current only at the time of printing. This document was printed on 7 August 2020. A current copy is located at https://apvma.gov.au/node/62211
You are here
Proposed approval of the new active constituent Erysipelothrix rhusiopathiae strain 31, and the registration of the product, Eryvac E-Oral (Live) Vaccine for Pigs
This consultation closed on 24 February 2020.
The APVMA is considering an application to register the new product Eryvac E-Oral (Live) Vaccine for Pigs and for the approval of the new active constituent Erysipelothrix rhusiopathiae strain 31.
We invite comment from 28 January 2020 to 24 February 2020 on whether the application for registration of the product and approval of the active constituent should be granted.
The APVMA is able to consider comments relating to the legislative grounds for registration, including:
- chemistry and manufacture
- occupational health and safety
- public health
- safety and first aid
- environmental safety
- efficacy and target animal safety
For more information, see page 27 of Gazette No. 2, 28 January 2020.
Please send your written submission by email or post to:
Australian Pesticides and Veterinary Medicines Authority
GPO Box 3262
Sydney NSW 2001
Phone: +61 2 6770 2300